Grow your business safely with AFFLUENT MEDICAL

All the information you need about AFFLUENT MEDICAL to develop and secure your business in France

A HOME > CORPORATES > AFFLUENT MEDICAL > BALANCE SHEET ( 2019-10-03)

THE LIST OF BALANCE SHEET : AFFLUENT MEDICAL

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-06-22 Public 2021-12-31 Consolidated
2021-04-28 Public 2020-12-31 Complete
2020-07-23 Public 2019-12-31 Complete
2019-10-03 Public 2018-12-31 Complete
NameAFFLUENT MEDICAL
Siren837722560
Closing2018-12-31
Registry code 1301
Registration number 12266
Management number2019B02325
Activity code 2370Z
Closing date n-11901-01-01
Duration Fiscal year 11
Duration Fiscal year n-100
Filing date2019-10-03
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address13100 AIX EN PROVENCE
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AR Technical installations, industrial equipment and tools 12 319.00 546.00 11 772.00 12 319.00
AT Other tangible assets 1 946.00 168.00 1 777.00 1 946.00
BD Other fixed assets 2 850 000.00 2 850 000.00 2 850 000.00
BH Other financial assets 171 000.00 171 000.00 171 000.00
BJ TOTAL (I) 62 535 152.00 715.00 62 534 437.00 62 535 152.00
BX Customers and related accounts 2 398 627.00 2 398 627.00 2 398 627.00
BZ Other receivables 7 395 247.00 7 395 247.00 7 395 247.00
CF Cash and cash equivalents 2 857 310.00 2 857 310.00 2 857 310.00
CH Prepaid expenses 10 475.00 10 475.00 10 475.00
CJ TOTAL (II) 12 661 660.00 12 661 660.00 12 661 660.00
CO Grand total (0 to V) 75 196 813.00 715.00 75 196 097.00 75 196 813.00
CU Other investments 59 499 886.00 59 499 886.00 59 499 886.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 11 899 967.00 11 899 967.00
DB Share, merger, contribution premiums, etc. 47 646 471.00 47 646 471.00
DI RESULTS FOR THE YEAR (Profit or Loss) -532 843.00 -532 843.00
DL TOTAL (I) 59 013 594.00 59 013 594.00
DS Convertible Bond Issues 6 152 671.00 6 152 671.00
DU Loans and Debts from Credit Institutions (3) 3 872 365.00 3 872 365.00
DV Miscellaneous Loans and Financial Debts (4) 5 067 147.00 5 067 147.00
DX Trade payables and related accounts 470 714.00 470 714.00
DY Tax and social security liabilities 600 017.00 600 017.00
EA Other liabilities 19 587.00 19 587.00
EC TOTAL (IV) 16 182 503.00 16 182 503.00
EE Grand total (I to V) 75 196 097.00 75 196 097.00
EG Accrued income and payables due within one year 6 844 970.00 6 844 970.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FG Production sold - services 1 998 855.00 1 998 855.00 1 998 855.00
FJ Net sales 1 998 855.00 1 998 855.00 1 998 855.00
FQ Other income 3.00
FR Total operating income (I) 1 998 858.00
FW Other purchases and external expenses 1 727 536.00
FX Taxes, duties, and similar payments 3 491.00
FY Salaries and Wages 342 525.00
FZ Social Security Contributions 154 684.00
GA Operating Expenses - Depreciation and Amortization 715.00
GE Other Expenses 109 032.00
GF Total Operating Expenses (II) 2 337 984.00
GG - OPERATING RESULT (I - II) -339 125.00
GJ Financial income from other securities and fixed asset receivables 171 000.00
GL Other interest and similar income 4 620.00
GP Total financial income (V) 175 620.00
GR Interest and similar expenses 369 337.00
GU Total financial expenses (VI) 369 337.00
GV - FINANCIAL INCOME (V - VI) -193 717.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -532 843.00
4 - Income statement (continued)Amount year NAmount year N-1
HL TOTAL REVENUE (I + III + V + VII) 2 174 478.00 2 174 478.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 2 707 321.00 2 707 321.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -532 843.00 -532 843.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 62 535 153.00
I3 DECREASES Total Financial Fixed Assets 62 520 887.00
I4 DECREASES Grand Total 62 535 153.00
IY DECREASES Total Tangible Fixed Assets 14 266.00
LN ACQUISITIONS Total Tangible Fixed Assets 14 266.00
LQ ACQUISITIONS Total Financial Fixed Assets 62 520 887.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 716.00
QU DEPRECIATION Total Tangible Fixed Assets 716.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
7Y Gross convertible bonds with a maturity of up to one year 6 152 671.00 6 152 671.00 6 152 671.00
8B Suppliers and Related Accounts 470 714.00 470 714.00 470 714.00
8C Staff and Related Accounts 58 678.00 58 678.00 58 678.00
8D Social Security and Other Social Organizations 106 695.00 106 695.00 106 695.00
8K Other liabilities (including liabilities related to repo transactions) 9 995.00 9 995.00 9 995.00
UT Other financial assets 171 000.00 171 000.00 171 000.00
UX Other trade receivables 2 398 627.00 2 398 627.00 2 398 627.00
UZ Social Security, other social security organizations 1 115.00 1 115.00 1 115.00
VB VAT 240 978.00 240 978.00 240 978.00
VC Group and associates 7 153 154.00 7 153 154.00 7 153 154.00
VG Loans with a maturity of up to one year at origin 368.00 368.00 368.00
VH Loans with a maturity of more than one year at origin 3 871 998.00 687 136.00 3 184 862.00 3 871 998.00
VI Group and Associates 5 076 739.00 5 076 739.00 5 076 739.00
VQ Other Taxes, Duties, and Similar Debts 32 088.00 32 088.00 32 088.00
VS Prepaid expenses 10 476.00 10 476.00 10 476.00
VT TOTAL – STATEMENT OF RECEIVABLES 9 975 350.00 9 804 350.00 171 000.00 9 975 350.00
VW VAT 402 557.00 402 557.00 402 557.00
VY TOTAL – STATEMENT OF LIABILITIES 16 182 503.00 6 844 970.00 9 337 533.00 16 182 503.00
16 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
YP Average staff number 2.00 2.00

all companies in France

Complete and comprehensive database.